Work

Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.10.169

Authors: Terrence C. Tsou, Kyle Gowen, Siraj M. Ali, Vincent A. Miller, Alexa B. Schrock, Christine M. Lovly, Karen L. Reckamp

Institutions: City Of Hope National Medical Center, City of Hope, Foundation Medicine (United States), Vanderbilt University Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, AstraZeneca, Ariad Pharmaceuticals

OpenAlex ID: W2911670622

FWCI: 0.494

Cites: 5

Cited by: 4

Related to: 10